GGRCX
Price
$14.87
Change
-$0.20 (-1.33%)
Updated
Jun 13 closing price
Net Assets
195.13M
VIGRX
Price
$215.38
Change
-$2.91 (-1.33%)
Updated
Jun 13 closing price
Net Assets
293.94B
Interact to see
Advertisement

GGRCX vs VIGRX

Header iconGGRCX vs VIGRX Comparison
Open Charts GGRCX vs VIGRXBanner chart's image
Goldman Sachs Strategic Growth C
Price$14.87
Change-$0.20 (-1.33%)
VolumeN/A
Net Assets195.13M
Vanguard Growth Index Investor
Price$215.38
Change-$2.91 (-1.33%)
VolumeN/A
Net Assets293.94B
GGRCX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGRCX vs. VIGRX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRCX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. GGRCX (195M). VIGRX pays higher dividends than GGRCX: VIGRX (0.35) vs GGRCX (0.00). GGRCX was incepted earlier than VIGRX: GGRCX (26 years) vs VIGRX (33 years). GGRCX (2.07) is less costly to investors than VIGRX (0.17). GGRCX is a more actively managed with annual turnover of: 39.00 vs. VIGRX (11.00). GGRCX has a lower initial minimum investment than VIGRX: GGRCX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 14.13 vs. GGRCX (9.52). VIGRX return over 5 years is better than : 118.13 vs. GGRCX (-6.46).
GGRCXVIGRXGGRCX / VIGRX
Total Expense Ratio1.780.171,047%
Annual Report Gross Expense Ratio2.070.171,218%
Fund Existence26 years33 years-
Gain YTD2.1003.31363%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets195M294B0%
Annual Yield % from dividends0.000.35-
Returns for 1 year9.5214.1367%
Returns for 3 years56.1794.2460%
Returns for 5 years-6.46118.13-5%
Returns for 10 years-52.70291.78-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX0.810.11
+15.37%
Lineage Cell Therapeutics
EXPD114.26-0.32
-0.28%
Expeditors International of Washington
COGT7.08-0.14
-1.94%
Cogent Biosciences
UAA6.60-0.24
-3.51%
Under Armour
PETZ1.05-0.05
-4.55%
TDH Holdings